Squalene Market Size Projected to Reach USD 266.74 Million by 2032

The Global Squalene Market Size Was Valued at USD 157.75 Million in 2023 and is Projected to Reach USD 266.74 Million by 2032, Growing at a CAGR of 6.01%.

According to a new report published by Introspective Market Research, Squalene Market by Source, Application, and End-Use Industry, The Global Squalene Market Size Was Valued at USD 157.75 Million in 2023 and is Projected to Reach USD 266.74 Million by 2032, Growing at a CAGR of 6.01%.

Market Overview:

The Squalene Market is witnessing steady growth driven by increasing demand across cosmetics, pharmaceuticals, and nutraceutical industries. Squalene is a naturally occurring organic compound traditionally sourced from shark liver oil and increasingly derived from plant-based sources such as olives, amaranth, and sugarcane. It is widely valued for its antioxidant, moisturizing, and immune-boosting properties.

Growth Driver:

A key growth driver of the Squalene Market is the rising demand for natural and sustainable cosmetic ingredients. Consumers are increasingly seeking clean-label, plant-based, and cruelty-free beauty products. Squalene, particularly plant-derived variants, aligns with these preferences due to its natural moisturizing properties and skin compatibility. Additionally, the expanding global skincare market and growing awareness of anti-aging solutions are boosting product formulations that incorporate squalene. Regulatory encouragement for sustainable sourcing and ethical alternatives to shark-derived ingredients further supports the transition toward plant-based and biosynthetic squalene production.

Market Opportunity:

A major opportunity in the Squalene Market lies in the expansion of vaccine development and advanced pharmaceutical applications. Squalene is a critical component in vaccine adjuvants, enhancing immune response effectiveness. With ongoing investments in global immunization programs and preparedness for emerging infectious diseases, demand for high-purity squalene is expected to grow. Furthermore, advancements in biotechnology are enabling scalable biosynthetic production methods, reducing dependence on traditional sources. This innovation opens new opportunities for pharmaceutical-grade squalene while addressing sustainability concerns and expanding market accessibility.

The Squalene Market is segmented on the basis of Source, Application, and End-Use Industry.

Source

The Source segment is further classified into Animal-Based Squalene, Plant-Based Squalene, and Synthetic/Biosynthetic Squalene. Among these, the Plant-Based Squalene sub-segment accounted for the highest market share in 2023. The dominance of plant-based squalene is driven by growing consumer preference for vegan and cruelty-free products. Olive-derived squalene, in particular, is widely used due to its stability and skin-friendly properties. Sustainability concerns surrounding shark-derived squalene have significantly shifted demand toward renewable plant sources, encouraging manufacturers to invest in eco-friendly extraction and processing technologies.

Application

The Application segment is further classified into Cosmetics & Personal Care, Pharmaceuticals, and Nutraceuticals. Among these, the Cosmetics & Personal Care sub-segment accounted for the highest market share in 2023. Squalene is extensively used in moisturizers, serums, sunscreens, and anti-aging creams due to its excellent emollient and antioxidant characteristics. Its ability to mimic natural skin lipids enhances absorption and hydration, making it a preferred ingredient in premium skincare formulations. Rising disposable income and increasing beauty awareness globally further strengthen this segment’s market leadership.

Some of The Leading/Active Market Players Are-

  • Kishimoto Special Liver Oil Co., Ltd. (Japan)
    • Amyris, Inc. (USA)
    • Croda International Plc (UK)
    • Nucelis LLC (USA)
    • Arbee Biomarine Extracts Pvt. Ltd. (India)
    • Sophim (France)
    • Evonik Industries AG (Germany)
    • SeaDragon Marine Oils Limited (New Zealand)
    • Cargill, Incorporated (USA)
    • VESTAN (Spain)
    • Maruha Nichiro Corporation (Japan)
    • EFKO Group (Russia)
    • Gracefruit Limited (UK)
    and other active players.

Key Industry Developments

News 1:
In May 2024, a biotechnology company announced expanded production capacity for sugarcane-derived biosynthetic squalene to meet growing cosmetic and pharmaceutical demand.

The expansion focuses on sustainable fermentation-based processes, significantly reducing reliance on animal-derived sources. This development strengthens supply chain stability and supports the global shift toward environmentally responsible ingredient sourcing in personal care and healthcare industries.

News 2:
In October 2023, a major cosmetic ingredient manufacturer launched a high-purity plant-based squalene line targeting premium skincare brands.

The new product line emphasizes traceability, ethical sourcing, and improved oxidative stability. This initiative responds to rising consumer demand for clean-label beauty products and reinforces the company’s strategic positioning in the natural ingredients segment.

Key Findings of the Study

  • Plant-Based Squalene dominates the source segment.
    • Cosmetics & Personal Care leads application demand.
    • North America and Europe are key revenue-generating regions.
    • Growth driven by clean-label and vaccine applications.
    • Biosynthetic production is an emerging market trend.